Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 211-220 of 290 for lung cancer

Edit search filters
  1. Pembrolizumab Plus Epacadostat Alone Or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo In Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306)

    Rochester, MN

  2. A Study To Assess The Effectiveness, Safety, And Drug/Body Interactions Of Rovalpituzumab For Third-Line And Later Treatment Of Patients With Small Cell Lung Cancer That Has Returned Or Is Resistant To Treatment

    Rochester, MN

  3. Study Of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily And In Combination With Dabrafenib Twice Daily And Trametinib Once Daily In Combination Therapy In Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer

    Rochester, MN

  4. A Study Of Amivantamab In Combination With Lazertinib, Or Amivantamab In Combination With Platinum-Based Chemotherapy, For Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    Jacksonville, FL, Rochester, MN

  5. A Study To Evaluate Adverse Events And Change In Disease Activity Of Intravenous ABBV-706 Versus Standard Of Care In Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  6. Safety Study Of Enoblituzumab (MGA271) In Combination With Pembrolizumab In Refractory Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Lung Nodule Management And Lung Cancer Screening In Patients With Abnormal Ct-Scan

    Jacksonville, FL

  8. A Study To Predict Lung Cancer Using Noninvasive Biomarkers

    Rochester, MN

  9. A Registry For People With Lung Cancer

    Jacksonville, FL, Rochester, MN

  10. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study In Lung (DELFI-L201)

    Rochester, MN

.

Mayo Clinic Footer